Access, Utilization and Outcomes of Cancer Services in the Era of Telemedicine
远程医疗时代癌症服务的获取、利用和结果
基本信息
- 批准号:10559541
- 负责人:
- 金额:$ 35.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-02-01 至 2027-01-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
ABSTRACT
Use of telehealth has skyrocketed since the start of the COVID-19 pandemic. Pre-pandemic, only 60,000 of the
63 million fee-for-service Medicare beneficiaries received a telehealth service each month compared to 24.5
million from March to October, 2020, with wide geographic variation in that uptake (e.g. 8.4% in South Dakota
to 47.6% in Massachusetts). This telehealth expansion comes at a time when the often-severe access issues
for rural individuals have become a focus for health policy and equity. Longer travel times for rural cancer
patients have been shown to negatively impact treatment regimens, RCT participation, and symptom
management. Multi-specialist teams are often required for comprehensive cancer care, making care
coordination in rural areas particularly challenging. These barriers have contributed to the widening gap in
cancer mortality between rural and urban patients. Measuring access to cancer care is a fundamental
component of both identifying gaps in access, as well as developing care delivery models to mitigate
disparities. Because telehealth transcends geographic proximity, it holds great promise for addressing rural
cancer care access inequities. Telehealth allows specialists to connect with geographically distant patients and
providers who otherwise would have had more restricted options for referral. With the expected persistence of
expanded telehealth following the COVID-19 pandemic, the time is now to develop new ways to measure
access to cancer care that integrate geospatial measures with telehealth and referral patterns in order to
improve equity in health care access and outcomes. Telehealth is now integral to rural cancer care in some
regions, yet where gaps are in its use and how inequities in access impact utilization and outcomes is
unknown. Only by measuring the new reality of cancer care access that includes telehealth, understanding
telehealth impacts on outcomes, and applying this evidence to “what if” scenarios/projections, can we begin to
harness and proactively direct the potential that telehealth has to reduce rural cancer disparities. This study will
take the critical and timely steps of developing measures of access nationally that incorporate telehealth,
identifying determinants of telehealth use in cancer care, testing effects of telehealth on cancer outcomes, and
analyzing the projected impact on equity in cancer care access and outcomes if telehealth use in cancer is
expanded, while considering differential effects based on the rural-urban continuum. To do this, we will use
national Medicare claims for telehealth utilization among cancer patients, Federal Communications
Commission (FCC) broadband data, and 2020 Census data for the entire U.S., to extend our prior geospatial
cancer care access work (R21CA212687) and population-based outcomes modeling with policy relevance.
抽象的
自从19日大流行开始以来,远程医疗的使用飙升。大流行,只有60,000
每月有6300万收费的医疗保险受益人接受远程医疗服务,而24.5
从2020年3月到10月,百万美元的地理差异很大(例如,南达科他州8.4%
在马萨诸塞州为47.6%)。这种远程医疗扩展是在经常访问问题的时候
对于粗糙的人来说,已经成为卫生政策和公平的重点。粗糙的人的旅行时间更长
已显示患者对治疗方案,RCT参与和症状产生负面影响
管理。全面的癌症护理通常需要多专业团队
在粗糙地区的协调特别具有挑战性。这些障碍有助于扩大差距
粗糙患者和城市患者之间的癌症死亡率。衡量获得癌症护理的机会是基本
识别访问中差距的组成部分,以及开发护理交付模型以减轻
差异。因为远程医疗超越地理位置,它具有解决节奏的巨大希望
癌症护理进入不平等。远程医疗允许专家与地理上遥远的患者建立联系,
否则将有更多限制的转诊选择的提供者。与预期的持久性
扩大了远程医疗,远程医疗是在COVID-19大流行之后,现在是时候开发新的方法来衡量
获得癌症护理,将地理空间措施与远程医疗和推荐模式相结合
提高医疗保健获得和成果的股权。远程医疗现在是某些农村癌症护理不可或缺的一部分
区域,差距在其使用方面以及访问的不平等影响如何影响利用率和结果
未知。仅通过衡量包括远程医疗在内的癌症护理获取的新现实,了解
远程医疗会影响结果,并将这些证据应用于“如果”场景/预测,我们可以开始
利用并主动指导远程医疗减少农村癌症差异的潜力。这项研究会
采取在全国范围内制定远程医疗的关键和及时步骤,
识别远程医疗在癌症护理中使用的决定者,远程医疗对癌症结果的影响以及
如果在癌症中使用远程医疗是
扩展,同时考虑基于崎ublan untumum的差异效应。为此,我们将使用
癌症患者远程医疗利用的国家医疗保险索赔,联邦通信
委员会(FCC)宽带数据和2020年全美国人口普查数据,以扩展我们以前的地理空间
癌症护理访问工作(R21CA212687)和基于人群的结果建模具有政策相关性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Tracy Onega的其他基金
Community Services Navigation to Advance Health Equity in Breast Cancer Screening
社区服务导航促进乳腺癌筛查健康公平
- 批准号:1071995710719957
- 财政年份:2023
- 资助金额:$ 35.47万$ 35.47万
- 项目类别:
Access, Utilization and Outcomes of Cancer Services in the Era of Telemedicine
远程医疗时代癌症服务的获取、利用和结果
- 批准号:1036864210368642
- 财政年份:2022
- 资助金额:$ 35.47万$ 35.47万
- 项目类别:
Breast Cancer Screening Strategies in the Era of New Technologies
新技术时代的乳腺癌筛查策略
- 批准号:99828269982826
- 财政年份:2020
- 资助金额:$ 35.47万$ 35.47万
- 项目类别:
Automated Delineation of Cancer Service Areas
自动划定癌症服务区域
- 批准号:93876069387606
- 财政年份:2017
- 资助金额:$ 35.47万$ 35.47万
- 项目类别:
Effectiveness of Pre-Operative MRI in Breast Cancer Surgery and Outcomes
术前 MRI 在乳腺癌手术中的有效性和结果
- 批准号:83185678318567
- 财政年份:2011
- 资助金额:$ 35.47万$ 35.47万
- 项目类别:
Improving Breast Cancer Screening Systems through Measurement 8 Feedback
通过测量 8 反馈改善乳腺癌筛查系统
- 批准号:85555408555540
- 财政年份:2011
- 资助金额:$ 35.47万$ 35.47万
- 项目类别:
Community-based Utilization of Breast Imaging Technologies
乳腺成像技术的社区利用
- 批准号:85555318555531
- 财政年份:2011
- 资助金额:$ 35.47万$ 35.47万
- 项目类别:
Effectiveness of Pre-Operative MRI in Breast Cancer Surgery and Outcomes
术前 MRI 在乳腺癌手术中的有效性和结果
- 批准号:87012478701247
- 财政年份:2011
- 资助金额:$ 35.47万$ 35.47万
- 项目类别:
Effectiveness of Pre-Operative MRI in Breast Cancer Surgery and Outcomes
术前 MRI 在乳腺癌手术中的有效性和结果
- 批准号:81065308106530
- 财政年份:2011
- 资助金额:$ 35.47万$ 35.47万
- 项目类别:
Effectiveness of Pre-Operative MRI in Breast Cancer Surgery and Outcomes
术前 MRI 在乳腺癌手术中的有效性和结果
- 批准号:88958568895856
- 财政年份:2011
- 资助金额:$ 35.47万$ 35.47万
- 项目类别:
相似国自然基金
采用新型视觉-电刺激配对范式长期、特异性改变成年期动物视觉系统功能可塑性
- 批准号:32371047
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
破解老年人数字鸿沟:老年人采用数字技术的决策过程、客观障碍和应对策略
- 批准号:72303205
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
通过抑制流体运动和采用双能谱方法来改进烧蚀速率测量的研究
- 批准号:12305261
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
采用多种稀疏自注意力机制的Transformer隧道衬砌裂缝检测方法研究
- 批准号:62301339
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
政策激励、信息传递与农户屋顶光伏技术采用提升机制研究
- 批准号:72304103
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Implementation Evaluation of PACT Pharmacy Management of Heart Failure in VISN 21
VISN 21 心力衰竭 PACT 药房管理实施评价
- 批准号:1075338810753388
- 财政年份:2023
- 资助金额:$ 35.47万$ 35.47万
- 项目类别:
Increasing initiation of evidence-based weight loss treatment
越来越多地开始开展循证减肥治疗
- 批准号:1073520110735201
- 财政年份:2023
- 资助金额:$ 35.47万$ 35.47万
- 项目类别:
NIDA Clinical Trials Network: New York Node
NIDA 临床试验网络:纽约节点
- 批准号:1085562710855627
- 财政年份:2023
- 资助金额:$ 35.47万$ 35.47万
- 项目类别:
Integrating Tailored Postoperative Opioid Tapering and Pain Management Support for Patients on Long-Term Opioid Use Presenting for Spine Surgery (MIRHIQL)
为脊柱手术中长期使用阿片类药物的患者整合定制的术后阿片类药物逐渐减量和疼痛管理支持 (MIRHIQL)
- 批准号:1072294310722943
- 财政年份:2023
- 资助金额:$ 35.47万$ 35.47万
- 项目类别:
Screening and Brief Intervention for Prescription Stimulant Misuse and Diversion: Refining and Piloting a Curriculum for College Health Providers
针对处方兴奋剂滥用和转移的筛查和简短干预:为大学医疗服务提供者完善和试点课程
- 批准号:1073112210731122
- 财政年份:2023
- 资助金额:$ 35.47万$ 35.47万
- 项目类别: